Prospective study of brain natriuretic peptide in pregnant women with heart failure and congenital heart defects

Authors

  • Ю. В. Давыдова Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
  • Л. Г. Воронков National Center «Institute of Cardiology named after M.D. Strazhesko», Ukraine
  • І. В. Чібісова Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
  • А. Ю. Лиманська Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
  • О. М. Мокрик Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
  • А. О. Огородник Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2013.12.42-45

Keywords:

pregnancy, heart failure, congenital heart defects, brain natriuretic peptide

Abstract

The fi rst study in Ukraine on the analysis of the level of brain natriuretic peptide (BNP) in pregnancy in women with congenital heart defects was performed. The results of this study showed that the level of BNP is a valuable diagnostic and prognostic marker of heart failure and a predictor of pregnancy complications in women with congenital heart defects. Due the value of BNP growth in pregnancy it can predict the tactics of pregnancy, timing and nature of the delivery, to develop individual therapy indications for maintenance of pregnancy.

Author Biographies

Ю. В. Давыдова, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

MD, head of the department of obstetric problems extragenital

Л. Г. Воронков, National Center «Institute of Cardiology named after M.D. Strazhesko»

MD, professor, Head of the Heart Failure Department

І. В. Чібісова, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

Head of the Obstetrics and Gynecological Care Department of Ministry of Health of Ukraine

А. Ю. Лиманська, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

PhD, senior researcher, Obstetrical Problems of Extragenital Pathology Department

О. М. Мокрик, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

PhD, researcher, Obstetrical Problems of Extragenital Pathology Department

А. О. Огородник, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

PhD, junior researcher, Obstetrical Problems of Extragenital Pathology Department

References

  1. Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, de Lemos JA Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol. 2007 Jan 2; 49 (1): 109–16.
  2. Clerico A, Zucchelli CG, Pilo A, Passino C, Emdin M Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-pro BNP assay. Clin Chem Lab Med. 2006; 44(4): 366–78.
  3. Kale A, Kale E, Yalinkaya A, Akdeniz N, Canoruc N The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy. J Perinat Med. 2005; 33(2):121–4.
  4. Kaleschke G, Baumgartner H Pregnancy in congenital and valvular heart disease. // Heart 2011, November; 97 (21): 1803–9.
  5. Lev-Sagie A, Bar-Oz B, Salpeter L, Hochner-Celnikier D, Arad I, Nir A Plasma Concentrations of N-Terminal Pro-B-Type Natriuretic Peptide in Pregnant Women near Labor and during Early Puerperium. Clin Chem. 2005 Oct; 51 (10): 1909–10.
  6. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L Congenital heart disease in the general population: changing prevalence and age distribution // Circulation 2007 January 16; 115 (2): 163–72.
  7. Pieper PG Prepregnancy risk assessment and counselling of the cardiac patient // Neth Heart J 2011, November; 19 (11): 477–81.
  8. Regitz-Zagrosek V, Blomstrom LC, Borghi C et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011, December; 32 (24): 3147–97.
  9. Tanous D, Siu S, Mason J, Greutmann M, Wald R, Parker J, Sermer M, Colman J Silversides C B-Type Natriuretic Peptide in Pregnant Women With Heart Disease // This work was supported by operating grants from the Heart and Stroke Foundation of Canada (NA 5927, NA 5662) and Canadian Institutes of Health Research (53030, 93722). The University of Toronto Pregnancy and Heart Disease Research Program acknowledges a generous donation from Mrs. Josephine Rogers. Dr. Siu is supported by the Ramsay Gunton Professorship in Cardiology of the Schulich School of Medicine and Dentistry. All other authors report that they have no relationships to disclose.Reprint requests and correspondence: Dr. Candice K. Silversides, Toronto General Hospital, 585 University Avenue, 5N-521, Toronto, Ontario M5G 2N2, Canada.
  10. American College of Cardiology Foundation.
  11. J Am Coll Cardiol. 2010; 56 (15): 1247–1253.
  12. Thorne S, MacGregor A, Nelson-Piercy C Risks of contraception and pregnancy in heart disease.Heart 2006 October; 92 (10): 1520–5.
  13. Van der Linde D, Konings EE, Slager MA et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis // J Am Coll Cardiol 2011 November 15; 58 (21): 2241–7.
  14. Yap SC, Drenthen W, Meijboom FJ et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect // BJOG 2009 November; 116 (12): 1593–601.
  15. Yap SC, Drenthen W, Pieper PG et al. Pregnancy outcome in women with repaired versus unrepaired isolated ventricular septal defect // BJOG 2010 May; 117 (6): 683–9.

Downloads

Published

2013-08-17

How to Cite

Давыдова, Ю. В., Воронков, Л. Г., Чібісова, І. В., Лиманська, А. Ю., Мокрик, О. М., & Огородник, А. О. (2013). Prospective study of brain natriuretic peptide in pregnant women with heart failure and congenital heart defects. REPRODUCTIVE ENDOCRINOLOGY, (12), 42–45. https://doi.org/10.18370/2309-4117.2013.12.42-45

Issue

No. 12 (2013)

Section

Pregnancy and childbirth

License

Copyright (c) 2014 Ю. В. Давыдова, Л. Г. Воронков, Л. Г. Воронков, І. В. Чібісова, І. В. Чібісова, А. Ю. Лиманська, А. Ю. Лиманська, О. М. Мокрик, О. М. Мокрик, А. О. Огородник, А. О. Огородник

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.